Column: Here’s why the arguments against canceling student debt make no sense

Motley Fool

Moderna Just Made a $700,000 Mistake

Moderna (NASDAQ: MRNA) is having a terrific year, raking in profits and generating plenty of cash due to its COVID-19 vaccine. As its business grows and the company plans for a post-COVID future, it needs to make smart decisions with its money. On May 9, Jorge Gomez was set to become Moderna’s CFO, replacing David Meline, who is planning to retire.